Kriya Therapeutics raises $320M to advance gene therapy programs
RTP-based Kriya Therapeutics has closed a $320 million Series D round co-led by Patient Square Capital and Premji Invest, with participation from Peter Thiel and others. The fundin…
RTP-based Kriya Therapeutics has closed a $320 million Series D round co-led by Patient Square Capital and Premji Invest, with participation from Peter Thiel and others. The fundin…